NEVUS OUTREACH INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Principal Officer

LAUREN ISBELL

Phone

9183310595

Tax Period

2023-01-01 to 2023-12-31

NEVUS OUTREACH INC is a small nonprofit in the Health Care sector that reported $213K in total revenue in fiscal year 2023. Revenue fell 24% from the prior year — a significant decline worth monitoring. Expenses of $253K exceeded revenue, resulting in a 18% operating deficit.

Mission

NEVUS OUTREACH IS DEDICATED TO BRINGING AWARENESS, PROVIDING SUPPORT, FUNDING RESEARCH, PROVIDING A BIENNIAL CONFERENCE, AND FINDING CURES FOR PEOPLE AFFECTED BY CONGENITAL MELANOCYTIC NEVI RELATED DISORDERS. THE ORGANIZATION RAISES AWARENESS INTERNATIONALLY BY PUBLISHING INFORMATIONAL LITERATURE, HOSTING A WEBSITE WITH INFORMATION ABOUT THE CONDITION, WORKING WITH OTHER NEVUS ORGANIZATIONS WORLDWIDE TO RAISE AWARENESS ON RARE DISEASE DAY. IN ADDITION, THE INTERNATIONAL CONFERENCE AND REUNION PROVIDES EDUCATION AND CONNECTION FOR ALL AGES. PEOPLE FROM ALL OVER THE WORLD ATTEND THIS CONFERENCE. NEVUS OUTREACH FUNDS RESEARCH ADVANCING SCIENCE ON CONGENITAL MELANOCYTIC NEVI AND RELATED DISORDERS SUCH AS NEUROCUTANEOUS MELANOCYTOSIS.

Program Service Accomplishments

Program 1

Expenses: $191,099

NEVUS OUTREACH OFFERS THE MOST COMPREHENSIVE, UP-TO-DATE, PROFESSIONALLY- VETTED, MULTI-LINGUAL, LAY-PERSON APPROPRIATE INFORMATION ABOUT GIANT CONGENITAL NEVI AVAILABLE FROM ANY SINGLE SOURCE, AND DISTRIBUTES THIS INFORMATION TO FAMILIES, HEALTH CARE PROVIDERS AND THE GENERAL PUBLIC USING PRINTED MATERIALS, WWW.NEVUS.ORG, THE NEVUS OUTREACH WEBSITE, AND THROUGH SOCIAL MEDIA CONNECTIONS

Program 2

Expenses: $39,933 Revenue: $32,701

ON A 24/7 BASIS, NEVUS OUTREACH SUPPORTS PEOPLE AFFECTED BY GIANT CONGENITAL NEVI BY PROVIDING ANSWERS TO THEIR QUESTIONS AND CONNECTING THEM WITH OTHERS WHO CAN HELP THEM USING PRINTED MATERIALS...

ON A 24/7 BASIS, NEVUS OUTREACH SUPPORTS PEOPLE AFFECTED BY GIANT CONGENITAL NEVI BY PROVIDING ANSWERS TO THEIR QUESTIONS AND CONNECTING THEM WITH OTHERS WHO CAN HELP THEM USING PRINTED MATERIALS, IN-PERSON MEETINGS THROUGHOUT THE UNITED STATES, AND WWW.NEVUS.ORG, OUR WEBSITE DEVOTED TO ONLINE SUPPORT FOR PEOPLE AFFECTED BY GIANT NEVI AND THE NEVUS OUTREACH SUPPORT GROUP ON FACEBOOK CURRENTLY HAS OVER 4,000 MEMBERS AND IS OPEN TO ANYONE AFFECTED BY A GIANT CONGENITAL NEVUS

Program 3

Expenses: $18,690

NEVUS OUTREACH FUNDS BASIC SCIENCE AND PROMISING THERAPEUTICS THAT ARE DESIGNED TO FIND A CURE FOR GIANT CONGENITAL NEVI AND NEUROCUTANEOUS MELANOCYTOSIS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $178,119

Program Service Revenue $32,701

Investment Income $2,509

Other Revenue $0

TOTAL REVENUE $213,329

Expense Breakdown

Grants Paid $0

Salaries & Benefits $68,599

Fundraising Expenses $3,070

Program Expenses $249,722

Other Expenses $184,193

TOTAL EXPENSES $252,792

Year-over-Year Comparison

	2023	2022	Change
Revenue	$213,329	$280,897	-0.2%
Expenses	$252,792	$344,363	-0.3%
Net Income	$-39,463	$-63,466	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$63,500

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LAUREN ISBELL	CEO	40.00	Officer	$63,500	$0	$63,500
ANDREA BISCHOFF	BOARD MEMBER	N/A	Director	$0	$0	$0
JENNA CONNORS	BOARD MEMBER	N/A	Director	$0	$0	$0
ERIK GREGORY	BOARD MEMBER	N/A	Director	$0	$0	$0
MAGGIE MANGOLD	BOARD MEMBER	N/A	Director	$0	$0	$0
CRISTY PHILLIPS	BOARD MEMBER	N/A	Director	$0	$0	$0
MATTHEW ROGERS	BOARD MEMBER	N/A	Director	$0	$0	$0
MERILEE VANCE	BOARD MEMBER	N/A	Director	$0	$0	$0
WIATT BOWERS	CHAIR	N/A	Officer	$0	$0	$0
CARA DOLCHIN	TREASURER	N/A	Officer	$0	$0	$0
OLIVER HOLMES	SECRETARY	N/A	Officer	$0	$0	$0
LISA O'BRYAN	VICE CHAIR	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$213,329	$252,792	$126,308	$-39,463
2022	$280,897	$344,363	$168,605	$-63,466
2018	$309,100	$302,885	$133,971	$6,215